| 000 | 01569 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513155305.0 | ||
| 264 | 0 | _c19990105 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaran, A | |
| 245 | 0 | 0 |
_a2',5'-Oligoadenylate-antisense chimeras cause RNase L to selectively degrade bcr/abl mRNA in chronic myelogenous leukemia cells. _h[electronic resource] |
| 260 |
_bBlood _cDec 1998 |
||
| 300 |
_a4336-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenine Nucleotides _xgenetics |
| 650 | 0 | 4 |
_aEndoribonucleases _xgenetics |
| 650 | 0 | 4 |
_aEnzyme Activation _xgenetics |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xgenetics |
| 650 | 0 | 4 |
_aOligoribonucleotides _xgenetics |
| 650 | 0 | 4 |
_aRNA, Messenger _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aWaller, C F | |
| 700 | 1 | _aParanjape, J M | |
| 700 | 1 | _aLi, G | |
| 700 | 1 | _aXiao, W | |
| 700 | 1 | _aZhang, K | |
| 700 | 1 | _aKalaycio, M E | |
| 700 | 1 | _aMaitra, R K | |
| 700 | 1 | _aLichtin, A E | |
| 700 | 1 | _aBrugger, W | |
| 700 | 1 | _aTorrence, P F | |
| 700 | 1 | _aSilverman, R H | |
| 773 | 0 |
_tBlood _gvol. 92 _gno. 11 _gp. 4336-43 |
|
| 999 |
_c9798319 _d9798319 |
||